In this study, we found that S100A7 expression was negatively correlated with immunomodulators in head and neck squamous cell carcinoma, while was positively correlated in breast invasive carcinoma, liver hepatocellular carcinoma, prostate adenocarcinoma and thyroid carcinoma. This evidence concerns the gene S100A7 and prostate adenocarcinoma.